Əsas səhifə

Çap

Əks əlaqə

İnfo
Surgery for choroidal neovascularisation secondary to age-related macular degeneration

Mündəricat

Surgery for choroidal neovascularisation secondary to age-related macular degeneration

Sübutlu məlumatların xülasələri
04.08.2017 • Sonuncu dəyişiklik 04.08.2017
Editors

Surgical removal of choroidal neovascularisation in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration does not prevent visual loss compared to observation, and the risk of developing cataract and retinal detachment increases after surgery.

A Cochrane review included 3 studies with a total of 860 subjects. 2 studies (n=790) compared submacular surgery with observation in people affected by subfoveal neovascular age-related macular degeneration with or without extensive blood in the macula. There was no difference between macular surgery and observation regarding visual loss (RR 0.96, 95% CI 0.84 to 1.09) or visual gain (RR 1.06, 95% CI 0.75 to 1.51) of 2 or more lines at one year. The risk difference was -2% (95% CI -10% to 5%) and 1% (95% CI -4% to 6%) for visual loss and visual gain, respectively, thus excluding a large benefit with surgery also in terms of absolute risk in these patients. Cataract needing surgery (RR 8.69, 95% CI 4.06 to 18.61) and retinal detachment (RR 6.13, 95% CI 2.81 to 13.38) were more common among operated patients, and detachment occurred in 5% of patients with no extensive blood and in 18% of those with extensive blood beneath the macula.

A pilot study compared submacular surgery with laser photocoagulation (n=70). No difference between the two treatments could be demonstrated for any outcome measure, but estimates were very imprecise because of small sample size.

Ədəbiyyat

  1. Giansanti F, Eandi CM, Virgili G. Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration. Cochrane Database Syst Rev 2009 Apr 15;(2):CD006931.